Objective and design: The use of proton pump inhibitors in acid-related diseases such as peptic ulcer or erosive reflux oesophagitis is well established. The aim of the current nationwide, multicentre ...
RANIDO: A phase III clinical trial of racotumomab-alum or nimotuzumab versus docetaxel in advanced non-small cell lung cancer patients. Background: To date convincing clinical success with oncolytic ...
In a first-of-its kind study, young children undergoing heart surgery had similar results regardless of whether they received levosimendan intravenously or via inhalation. Pediatric patients who ...
Clinicians have a range of options for treating patients with disease states that require the use of immunoglobulin (Ig). Traditionally, intravenous immunoglobulin (IVIG) administration has provided ...
A phase II study of autologous tumor infiltrating lymphocytes (TIL, LN-144/LN-145) in patients with solid tumors. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract ...
A route of administration is a way that a drug can enter the body. There are many drug routes of administration, each suited to different situations. Each route has its benefits and potential risks.
New approaches for the prevention and elimination of malaria, a leading cause of illness and death among infants and young children globally, are needed. We conducted a phase 1 clinical trial to ...
The study underscores Small Pharma's core mission, which is patient access, CEO George Tziras says. The company hopes to be one step closer to understanding the potential efficacy of SPL026 as a ...
Please provide your email address to receive an email when new articles are posted on . Patients with an allergic inflammatory skin reaction to subcutaneous heparin generally tolerated IV ...
BETHLEHEM, Pa., Sept. 21, 2021 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced today the launch of its new CARESAFETM IV Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results